Kyverna Therapeutics Competitors and Similar CompaniesClear all
Jazz Pharmaceuticals's competitors and similar companies include Spexis and AlzProtect.
 Jazz Pharmaceuticals Jazz Pharmaceuticals is a biopharmaceutical company engaged in developing and marketing medicines for sleep disorders, epilepsy, and oncology. |  Spexis Spexis (formerly known as Polyphor) is a bioengineering company that specializes in respiratory therapeutics. |  AlzProtect AlzProtect is a biopharmaceutical company discovering and developing drug candidates for the treatment of neurodegenerative diseases. | |
Founding Date | Founding Date 2003 | Founding Date 1996 | Founding Date 2007 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Dublin, IE HQ Mississauga, CA Vancouver, CA Lyon, FR München, DE Roscommon, IE Villa Guardia, IT see more | Locations Allschwil, CH HQ | Locations Loos, FR HQ Loos, FR |
Employees | Employees 2,800 | Employees 50 | Employees 1011% increase |
Financial | |||
Revenue (est.) | Revenue (est.) $4.3b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($356.1m) (FY, 2025) | Net income (CHF19.6m) (FY, 2023) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 384.1m | Total funding raised N/A | Total funding raised $ 19.8m |
For sources of this data, please see the company profile
View Company Profiles
Spexis
HQ
Allschwil, CH
Employees
50
Spexis (formerly known as Polyphor) is a bioengineering company that specializes in respiratory therapeutics.
View companyAlzProtect
HQ
Loos, FR
Employees
10↑ 11% increase
AlzProtect is a biopharmaceutical company discovering and developing drug candidates for the treatment of neurodegenerative diseases.
View company